Retatrutide, by Soma Pharmaceuticals , is attracting considerable attention as a potential therapy for weight management . This dual-action medication merges the mechanism of a GLP-1 receptor stimulant and a GIP receptor stimulant, aiming to simply promote weight loss but also improve related metabolic factors. Initial patient data have indicated i